Skip to content
← Learning library
Module 016 lessons

Nutrition Screening, Assessment, and Malnutrition

Move from a rapid nutrition risk screen to a defensible assessment, diagnosis, and monitoring plan.

01

Distinguish screening, assessment, diagnosis, intervention, and monitoring.

02

Collect and interpret weight, intake, functional, physical, and disease data.

03

Apply contemporary GLIM and Academy and ASPEN diagnostic frameworks.

04

Build a pharmacist focused nutrition problem list and follow up plan.

01.01

From Screening to Assessment

Screening identifies who may be at risk. Assessment determines what is happening, why it is happening, and what should happen next.

What to learn
  • Validated screening tools
  • Risk versus diagnosis
  • Referral and escalation
  • Repeat screening after clinical change
Clinical workflowRisk identification becomes useful only when the loop closes
01ScreenIdentify current risk

Use a validated tool that fits the population and care setting.

02AssessExplain the problem

Reconstruct intake, trajectory, tissue, function, disease, and confounders.

03ActAssign the next decision

Document referral, intervention, reassessment interval, and ownership.

Use the right tool for the right decision

Nutrition screening is intentionally brief. Tools such as MST, MUST, MNA-SF, and NRS-2002 use different populations and inputs, so the tool should match the care setting and local workflow. The result answers a narrow question: does this person need a more complete nutrition assessment?

Build a closed loop

A useful workflow links a positive screen to timely assessment, a documented plan, and reassessment. Risk changes with acute illness, procedures, poor intake, gastrointestinal losses, functional decline, and prolonged hospitalization.

0 of 1 answered
01A patient has a positive MST result on admission. What is the most appropriate next step?

Checking for saved practice…

Answer every question to submit.
01.02

History, Intake, and Disease Burden

Nutrition status is a trajectory. The history explains the direction and speed of change better than a single measurement.

What to learn
  • Usual and recent intake
  • Unintentional weight change
  • Symptoms and assimilation
  • Inflammation and disease burden
Clinical trajectoryMagnitude, duration, and mechanism turn history into evidence
01MeasureQuantify change

Compare usual and current intake, weight, symptoms, and function over a defined interval.

02ExplainLocate the mechanism

Separate access, appetite, swallowing, absorption, losses, inflammation, and demand.

03ContextExpose confounders

Review medicines, fluid shifts, procedures, anatomy, mood, and social conditions.

Quantify the trajectory

Record usual weight, current measured weight, the time interval, whether the change was intentional, and whether fluid shifts could distort the result. Estimate the proportion of usual intake being consumed and the duration of the reduction.

Identify the mechanism

Reduced intake can reflect nausea, pain, dysphagia, altered taste, depression, food insecurity, medication effects, or treatment schedules. Gastrointestinal symptoms such as vomiting and diarrhea can impair intake or assimilation. Review malabsorptive disorders, altered anatomy, and gastrointestinal losses as distinct mechanisms affecting nutrient availability. Disease burden can add inflammatory and catabolic stress.

0 of 1 answered
01Which history most strongly supports an etiologic GLIM criterion?

Checking for saved practice…

Answer every question to submit.
01.03

Anthropometrics and Body Composition

Weight and BMI are useful when their limitations are visible. Muscle and fat loss may be clinically important even when body weight appears ordinary.

What to learn
  • Measured height and weight
  • BMI and weight change
  • Fluid confounding
  • Muscle mass and body composition
Body measurementThe number is interpretable only when its conditions are visible
01BaselineChoose a credible comparator

Record whether prior height and weight were measured, reported, or estimated.

02CalculateShow the equation

Percent loss uses usual weight; BMI uses kilograms divided by meters squared.

03CorrectAccount for hidden tissue loss

Edema, ascites, obesity, amputation, and measurement conditions can distort inference.

Calculate before classifying

Percent weight loss equals usual weight minus current weight, divided by usual weight, multiplied by 100. BMI equals weight in kilograms divided by height in meters squared. Neither value should be interpreted without the clinical timeline and measurement conditions.

Recognize hidden depletion

Edema and ascites can mask tissue loss. A person with a high BMI can still have low muscle mass and clinically important malnutrition. Repeated measurements obtained under similar conditions are more informative than isolated values.

0 of 1 answered
01A patient with edema has lost visible muscle but weighs the same as last month. What is the best interpretation?

Checking for saved practice…

Answer every question to submit.
01.04

Physical and Functional Assessment

The bedside examination turns suspected tissue loss into observable evidence and helps distinguish fat, muscle, fluid, and function.

What to learn
  • Subcutaneous fat stores
  • Muscle groups
  • Edema and ascites
  • Functional change
Bedside evidenceName the tissue, the site, the degree, and the competing cause
01InspectFat and muscle compartments

Use defined bilateral sites and compare with age, habitus, mobility, and prior function.

02SeparateFluid from tissue

Edema and ascites can conceal depletion and should be documented as distinct findings.

03TestUse function in context

Grip, transfers, and mobility support assessment but remain sensitive to pain and illness.

Inspect specific tissue compartments

Nutrition focused examination evaluates fat stores, muscle groups, fluid accumulation, oral and skin findings, and functional clues. Findings should be interpreted with the history because immobility, denervation, aging, trauma, and organ disease can alter muscle independently of intake.

Treat function as context

A decline in grip, mobility, transfers, or usual activity can support the assessment, but function is affected by pain, cognition, neurologic disease, sedation, and acute illness. It should not be treated as a nutrition specific measurement in isolation.

0 of 1 answered
01Why should reduced handgrip strength not be interpreted alone as proof of malnutrition?

Checking for saved practice…

Answer every question to submit.
01.05

Diagnostic Frameworks

Diagnostic frameworks organize evidence. They do not replace clinical judgment, and their criteria should not be mixed casually.

What to learn
  • GLIM phenotypic criteria
  • GLIM etiologic criteria
  • Academy and ASPEN characteristics
  • Severity and etiology
Diagnostic reasoningUse one framework transparently instead of blending unrelated thresholds
01GLIMPhenotype plus etiology

After screening, diagnosis requires at least one phenotypic and one etiologic criterion.

02Academy and ASPENAt least two clinical characteristics

Interpret intake, weight, muscle, fat, fluid, and function within the etiologic context.

03LimitsDo not diagnose from albumin

Inflammation and fluid biology make visceral proteins risk markers, not tissue inventories.

Apply GLIM in two steps

After risk screening, GLIM diagnosis requires at least one phenotypic criterion and at least one etiologic criterion. Phenotypic criteria are weight loss, low BMI, and reduced muscle mass. Etiologic criteria are reduced intake or assimilation and inflammation or disease burden. Assess all five criteria where possible. A diagnosis can be established when at least one phenotypic and one etiologic criterion are demonstrated despite a practical barrier to other measurements; excluding malnutrition requires assessment of all five. Muscle strength may inform the wider assessment, but it is not a substitute for muscle mass in the GLIM diagnostic algorithm.

Apply Academy and ASPEN characteristics

The Academy and ASPEN adult framework evaluates insufficient energy intake, weight loss, loss of muscle mass, loss of subcutaneous fat, fluid accumulation, and diminished functional status measured by handgrip strength. At least two characteristics support diagnosis, interpreted within the relevant acute illness, chronic illness, or social and environmental context.

Do not diagnose from albumin

Albumin and prealbumin are influenced strongly by inflammation, capillary permeability, fluid status, organ function, and other factors. ASPEN does not recommend using them as proxy measures of total body protein or muscle mass, or as stand alone nutrition markers.

0 of 1 answered
01A patient has low BMI and reduced muscle mass but no evidence of reduced intake, malabsorption, or disease burden with inflammation. Does the patient meet GLIM diagnosis on the available data?

Checking for saved practice…

Answer every question to submit.
01.06

Plan, Monitor, and Communicate

An assessment becomes a care plan when the team names the problem, acts on its cause, measures benefit and harm, and assigns the next decision.

What to learn
  • Causal barriers and team roles
  • Risk-based safety monitoring
  • Patient outcomes and process measures
  • Fidelity and accountable follow-up
ImplementationEvery intervention needs a measure, interval, threshold, and owner
01PrioritizeTreat the causal barrier

Address swallowing, symptoms, medicines, access, restriction, and disease burden.

02MonitorPair benefit with safety

Track intake, weight, volume, function, symptoms, laboratories, and refeeding risk.

03ReviseClose the decision loop

State what success means, when to reassess, what triggers escalation, and who acts.

Connect cause to intervention

Investigate barriers such as nausea, constipation, dysphagia, pain, food access, and medicine effects before choosing an intervention. A symptom that follows a new medicine suggests a possible contribution, not proof of causation. Review its indication and alternatives with the prescriber, address other plausible causes, and measure the response. Coordinate dietitian, nursing, pharmacy, swallowing, and social support according to the problem; involve the patient in the plan.

Monitor benefit and harm from the start

Track actual intake and delivered feed, symptoms, weight with fluid balance, clinical condition, and relevant laboratory trends. The supplied book highlights glucose intolerance, electrolyte shifts, and fluid accumulation during parenteral nutrition. High refeeding risk calls for cautious, individualized initiation by an experienced team and planned surveillance, not aggressive feeding followed by optional monitoring. A new electrolyte decline or clinical deterioration requires prompt reassessment of feeding, replacement, and fluid management under the agreed protocol.

Choose intervals for the patient and setting

NICE CG32 provides adult nutrition-support monitoring examples. In hospital, initially assess intake daily and chart fluid balance during enteral or parenteral support. Check weight daily when fluid balance is a concern; otherwise use weekly weights, reducing frequency with stability. Its laboratory table calls for baseline tests, daily sodium, potassium, urea and creatinine until stable, glucose once or twice daily until stable, and daily magnesium and phosphate when refeeding risk is present. This table chiefly addresses parenteral nutrition and is selectively applicable to oral or enteral support. Acute instability may require more frequent assessment; these are not universal intervals for every patient.

Separate the patient result from delivery of care

Improved intake or relief of nausea is a patient outcome. Recording intake and completing an agreed medicine review are care processes. In the Proctor implementation framework, fidelity asks whether a pathway was delivered as intended; adherence to its required steps can be one fidelity measure. Adoption concerns initial uptake, acceptability asks whether the pathway is agreeable, and feasibility asks whether it can be carried out in the setting. A completed checklist does not itself prove clinical benefit. Document both the action taken and the patient response, with a named owner, next review, and agreed escalation threshold.

0 of 1 answered
01An adult inpatient has nausea and reduced intake. The team has agreed an intake goal and a safe medicine adjustment. Which follow-up plan is most actionable?

Checking for saved practice…

Answer every question to submit.

Check the connections.

Each attempt draws 10 questions from the complete 105 question bank.

105 questions in this module bank10 questions per attempt

Each attempt draws a fresh set and rearranges the answer choices.

Current clinical foundation.

Core source material was synthesized with the following contemporary guidance. Verify local policy and current guidance before applying clinical information.

  1. White et al. (2012): Academy and ASPEN adult malnutrition characteristics
  2. BAPEN MUST adult screening tool and measurement guidance
  3. Rydholm et al. (2023): joint inflammation and grip force in early rheumatoid arthritis
  4. Vanhorebeek et al. (2020): ICU-acquired weakness and assessment limitations
  5. BAPEN MUST explanatory booklet: measurement limitations
  6. ASPEN: Screening, assessment, and malnutrition diagnostic processes
  7. GLIM consensus approach, five year update
  8. ASPEN position paper on visceral proteins
  9. GLIM diagnostic criteria consensus report
  10. Missing data mechanisms and analysis in clinical trials
  11. STARD diagnostic accuracy methods
  12. COSMIN measurement properties and cross-cultural validity
  13. WHO cluster trial design and analysis
  14. NICE CG32: Adult nutrition support, recommendations and monitoring tables (updated 2017)
  15. Proctor et al. (2011): Implementation outcomes and fidelity
LearnOpen tools